Optimal anticoagulation and antithrombotic treatment after PCI in AF patients
Not Applicable
Recruiting
- Conditions
- Diseases of the circulatory system
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 960
Inclusion Criteria
1. Over 19 years old
2. Patient who underwent PCI with DES 12 months to 18 months ago
3. Non-valvular atrial fibrillation patients requiring long-term anticoagulation
Exclusion Criteria
1. Over 85 years old
2. Pregnancy or Potential Pregnancy
3. Life expectancy within 1 year
4. Patients who refuse or do not understand the written consent form
5. Requiring anticoagulation due to history of mechanical valve replacement, mitral stenosis or deep vein thrombosis
6. Coagulopathy, continuous bleeidng, or Hb level below 10 g/dL
7. Intracerebral hemorrhage within 2 months
8. Patients with gastrointestinal hemorrhage within three months of registration
9. Patients diagnosed with a gastrointestinal tumor that requires continuous treatment
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method et adverse clinical event (NACE) : Death, myocardial infarction, stent thrombosis, stroke, systemic embolism, major or clinically relevant non-major bleeding defined by International Society on Thrombosis and Haemostasis (ISTH)
- Secondary Outcome Measures
Name Time Method Incidence of each component of NACE;ISTH Major or clinically relevant minor bleeding;NACE or ISTH clinically relevant minor bleeding;All-cause or cardiovascular mortality;Major adverse cardiac event